{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 49,
        "end": 52
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 184,
        "end": 201
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 206,
        "end": 220
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 65,
        "end": 68
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 184,
        "end": 220
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23091097_11",
  "text": "CONCLUSION : The combination of 11q deletion and ATM mutation in CLL is associated with significantly shorter progression-free and overall survival following first-line treatment with alkylating agents and purine analogs ."
}
